134 related articles for article (PubMed ID: 1930826)
1. Structure of a new cyclotetrapeptide trapoxin A.
Nakai H; Nagashima K; Itazaki H
Acta Crystallogr C; 1991 Jul; 47 ( Pt 7)():1496-9. PubMed ID: 1930826
[TBL] [Abstract][Full Text] [Related]
2. Isolation and structural elucidation of new cyclotetrapeptides, trapoxins A and B, having detransformation activities as antitumor agents.
Itazaki H; Nagashima K; Sugita K; Yoshida H; Kawamura Y; Yasuda Y; Matsumoto K; Ishii K; Uotani N; Nakai H
J Antibiot (Tokyo); 1990 Dec; 43(12):1524-32. PubMed ID: 2276972
[TBL] [Abstract][Full Text] [Related]
3. Structure and conformations of two cycloisomeric hexapeptides: cyclo(L-Leu-L-Phe-Gly-D-Phe-L-Leu-Gly-) trihydrate and cyclo(L-Phe-L-Leu-Gly-D-Leu-L-Phe-Gly-) trihydrate.
Barnes CL; Hossain MB; Fidelis K; van der Helm D
Acta Crystallogr B; 1990 Apr; 46 ( Pt 2)():238-46. PubMed ID: 2344396
[TBL] [Abstract][Full Text] [Related]
4. Structures of quinoxaline antibiotics.
Sheldrick GM; Heine A; Schmidt-Bäse K; Pohl E; Jones PG; Paulus E; Waring MJ
Acta Crystallogr B; 1995 Dec; 51 ( Pt 6)():987-99. PubMed ID: 8554726
[TBL] [Abstract][Full Text] [Related]
5. Conformation of cyclic octapeptides. VI. Structure of cyclo-bis-(-L-alanyl-glycyl-L-prolyl-L-phenylalanyl-) tetrahydrate.
Bhandary KK; Kopple KD
Acta Crystallogr C; 1991 Jul; 47 ( Pt 7)():1483-7. PubMed ID: 1930824
[TBL] [Abstract][Full Text] [Related]
6. Conformation of cyclo-bis(-L-valyl-L-proplyl-D-alanyl-), a synthetic cyclic hexapeptide.
Bhandary KK
Acta Crystallogr C; 1991 Jun; 47 ( Pt 6)():1280-3. PubMed ID: 1953982
[TBL] [Abstract][Full Text] [Related]
7. Structure of benzyloxycarbonyl-L-isoleucyl-L-alanyl-alpha- aminoisobutyryl-alpha-aminoisobutyrate methyl ester, Z-L-Ile-L-Ala-Aib-Aib-OMe.
Taga T; Hourai S; Machida K; Fujita T; Ichihara T
Acta Crystallogr C; 1991 Jul; 47 ( Pt 7)():1494-6. PubMed ID: 1930825
[TBL] [Abstract][Full Text] [Related]
8. Structure of the cyclohexapeptide cleromyrine II trihydrate.
Declercq JP; Tinant B; Bashwira S; Hootelé C
Acta Crystallogr C; 1990 Jul; 46 ( Pt 7)():1259-62. PubMed ID: 2222931
[TBL] [Abstract][Full Text] [Related]
9. Structure of a protected C3-C10 subunit of erythromycin and its C8 epimer.
Lynch VM; Lee WC; Martin SF; Davis BE
Acta Crystallogr C; 1992 Jun; 48 ( Pt 6)():1145-8. PubMed ID: 1388943
[TBL] [Abstract][Full Text] [Related]
10. Structure of 5 beta-pregnane-3 alpha, 6 alpha, 17 alpha-triol triacetate.
Grochulski P; Wawrzak Z; Gałdecki Z; Duax WL; Strong PD
Acta Crystallogr C; 1992 Dec; 48 ( Pt 12)():2247-9. PubMed ID: 1292514
[TBL] [Abstract][Full Text] [Related]
11. Platelet activating factor antagonist design. 2. X-ray structure of dimethyl 2,3,4,5-tetrahydro-5 beta-(3,4-methylenedioxyphenyl)-2-oxo-3 beta-(3,4,5-trimethoxybenzoyl)-3 alpha,4 alpha-furandicarboxylate.
Peterson JR; Do HD; Rogers RD
Acta Crystallogr C; 1989 Jul; 45 ( Pt 7)():1059-63. PubMed ID: 2610989
[TBL] [Abstract][Full Text] [Related]
12. Structures of three DNA cross-linking agents, ethane-1,2-di(methylsulfonate), propane-1,3-di(methylsulfonate) and n-butane-1,4-di(methylsulfonate).
McKenna R; Neidle S; Kuroda R; Fox BW
Acta Crystallogr C; 1989 Feb; 45 ( Pt 2)():311-4. PubMed ID: 2558689
[TBL] [Abstract][Full Text] [Related]
13. Structures of N-acetylbenzamide, N-propionylbenzamide and N-butyrylbenzamide and analysis of imide hydrogen-bond patterns.
Etter MC; Britton D; Reutzel SM
Acta Crystallogr C; 1991 Mar; 47 ( Pt 3)():556-61. PubMed ID: 2069767
[TBL] [Abstract][Full Text] [Related]
14. Structure of 6-oxo-1,6-dihydro-3,4'-bipyridine-5-carbonitrile hydrogen bromide.
Cody V; Wojtczak A
Acta Crystallogr C; 1991 Aug; 47 ( Pt 8)():1742-4. PubMed ID: 1781963
[TBL] [Abstract][Full Text] [Related]
15. Structure of a key intermediate in the synthesis of (-)-5-carboxytetrahydroalstonine and (-)-tetrahydroalstonine.
Lynch VM; Corbett JW; Martin SF; Davis BE
Acta Crystallogr C; 1991 Feb; 47 ( Pt 2)():464-6. PubMed ID: 2025406
[TBL] [Abstract][Full Text] [Related]
16. 1,2-Naphthalenedicarboxylic acid: structures of channel clathrates and an unsolvated crystalline phase.
Fitzgerald LJ; Gallucci JC; Gerkin RE
Acta Crystallogr B; 1992 Jun; 48 ( Pt 3)():290-7. PubMed ID: 1388945
[TBL] [Abstract][Full Text] [Related]
17. Nucleic acid intercalating drug. The structure of 9-hydroxy-2,5,11- tetramethylpyrido[4,3-b]carbazolium (9-hydroxy-2,6- dimethylellipticinium) chloride monohydrate.
Salahou A; Courseille C; Tsai CC
Acta Crystallogr C; 1988 Dec; 44 ( Pt 12)():2126-8. PubMed ID: 3270553
[TBL] [Abstract][Full Text] [Related]
18. The structure at 198 K of (1R,5R,15R,16R)-5-isopropenyl-2-methyl- 1-[N-(trans-2-phenylcyclohexyloxycarbonyl)amino]-2-cyclohexene.
Lynch VM; Yaser HK; Whitesell JK; Davis BE
Acta Crystallogr C; 1991 Jul; 47 ( Pt 7)():1566-8. PubMed ID: 1930829
[TBL] [Abstract][Full Text] [Related]
19. Structure of 3-(4-methoxyphenyl)-4-phenyl-4H-1,2,4-triazole.
Rogers RD; Park MG; Kevill DN
Acta Crystallogr C; 1990 Nov; 46 ( Pt 11)():2218-21. PubMed ID: 2073374
[TBL] [Abstract][Full Text] [Related]
20. Structure and solution conformation of the cytostatic cyclic tetrapeptide WF-3161, cyclo[L-leucyl-L-pipecolyl-L-(2-amino-8-oxo-9, 10-epoxydecanoyl)-D-phenylalanyl].
Kawai M; Pottorf RS; Rich DH
J Med Chem; 1986 Nov; 29(11):2409-11. PubMed ID: 3783600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
